• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Alendronic Acid
    2 Drugs classified under this active ingredient


    All the Active Ingredient Drugs

    Binosto
    Tzamal
    RX
    partial basket chart
    Binosto

    Biphosphonate. Alendronic Acid 70 mg.
    EFFERVESCENT TABS: 4,12,24. 1 tab (70 mg)×1/week. Missed dose, should be taken one effervescent tab. on the morning after as pt. remembers and return to taking 1 tab (70 mg)×1/week , as original. scheduled on their chosen day.
    The tabs. must be taken at least 30 min. before the first food, beverage, or med. product of the day with plain water only. The drug should only be taken upon arising for the day dissolv. in half a glass of plain water (not less than 120 ml or 4.2 fl.oz.). Pts. should not lie down until after their 1st food of the day, which should be at least 30 min. after drinking the oral sol. Pts. should not lie down for at least 30 min. after taking, should not be taken at bedtime or before arising for the day, can be given to pts. who are unable or unwell. to swallow tabs. See lit.
    Tmt. of osteoporosis in postmenopaus. women to prevent fractures, include. those of the hip and spine (vertebral compres. fractures).
    Tmt. to incr. bone mass in men with osteoporosis.
    C/I: Hypersens. Abnormalities of the oesophagus and other factors which delay oesophageal emptying such as stricture or achalasia, Inability to stand or sit upright for at least 30 minutes. Hypocalcaemia.

    Fosavance
    MSD
    RX
    not in the basket chart
    Multiple ingredients
    Fosavance

    Bisphosphonate. Alendronic Acid 70 mg, Cholecalciferol 140 mcg.
    TABS: 4. 1 tab 1 x wkly at least 1/2 hr.
    bef. first food, beverage or medicat. of
    day, with full glass plain water only, to
    be swallowed whole, in upright
    position. Not to lie down for at least 30
    mins. and until after first food.
    Tmt. osteoporos. in postmenopaus.
    women, to reduce incidence fractures
    hip and spine, to incr. bone mass in men
    with osteoporos.
    C/I: Esophag. abnorms, inability to
    stand/sit upright for at least 30 mins.,
    hypocalcem., hypersens. See lit.

    CLOSE